Skip to main content
OpenTrials

Clinical trial condition

Endometrial Neoplasms

Explore clinical trials studying Endometrial Neoplasms. Study availability and eligibility vary by location and protocol.

77 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Neoplasms trial results

Active, Not Recruiting

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

NCT04269200

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Concord, California, United States
  • Research Site La Jolla, California, United States
  • Research Site San Francisco, California, United States
View all 201 locations
View Trial Details
Active, Not Recruiting

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

NCT04956640

Conditions
Adnexal Diseases, Biliary Tract Diseases, Biliary Tract Neoplasms, +36 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • USC Norris Cancer Hospital Los Angeles, California, United States
  • Chao Family Comprehensive Cancer Ctr. Orange, California, United States
  • Yale-New Haven Hospital New Haven, Connecticut, United States
View all 49 locations
View Trial Details
Active, Not Recruiting

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)

NCT05173987

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • HonorHealth-USOR HonorHealth ( Site 8000) Phoenix, Arizona, United States
  • Moores Cancer Center ( Site 0037) La Jolla, California, United States
  • Kaiser Permanente Riverside Medical Center ( Site 0045) Riverside, California, United States
  • Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0013) New Haven, Connecticut, United States
View all 194 locations
View Trial Details
Active, Not Recruiting

A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor

NCT04008797

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +25 more
Locations
  • UAMS Little Rock, Arkansas, United States
  • University of California San Diego (UCSD) - Moores Cancer Center(All) La Jolla, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Pasadena Liver Center Pasadena, California, United States
View all 106 locations
View Trial Details
Active, Not Recruiting

Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

NCT06714617

Conditions
Adnexal Diseases, Breast Cancer Stage III, Breast Diseases, +48 more
Locations
  • SCRI-Denver HealthOne Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • SCRI-Florida Cancer Center Specialists Lake Mary Lake Mary, Florida, United States
  • Hematology Oncology Associates of the Treasure Cost Port Saint Lucie, Florida, United States
View Trial Details
Active, Not Recruiting

The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma

NCT01820858

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • Qilu Hospital，Shandong University Jinan, Shandong, China
  • Women's Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
View Trial Details
Active, Not Recruiting

The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma

NCT01820884

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • Qilu Hospital，Shandong University Jinan, Shandong, China
  • Women's Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
View Trial Details

Related conditions